JoVE Logo

Anmelden

Chapter 10

Cardiovascular Drugs: Antiarrhythmic and Heart Failure Drugs

Elektrophysiologie des normalen Herzrhythmus
Elektrophysiologie des normalen Herzrhythmus
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process ...
Der Mechanismus von Herzrhythmusstörungen
Der Mechanismus von Herzrhythmusstörungen
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various ...
Antiarrhythmika: Wirkstoffe der Klasse I als Natriumkanalblocker
Antiarrhythmika: Wirkstoffe der Klasse I als Natriumkanalblocker
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the ...
Antiarrhythmika: Wirkstoffe der Klasse II als β-adrenerge Blocker
Antiarrhythmika: Wirkstoffe der Klasse II als β-adrenerge Blocker
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in ...
Antiarrhythmika: Wirkstoffe der Klasse III als Kaliumkanalblocker
Antiarrhythmika: Wirkstoffe der Klasse III als Kaliumkanalblocker
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium ...
Antiarrhythmika: Wirkstoffe der Klasse IV als Kalziumkanalblocker
Antiarrhythmika: Wirkstoffe der Klasse IV als Kalziumkanalblocker
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in ...
Pathophysiologie der Herzleistung
Pathophysiologie der Herzleistung
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct ...
Pathophysiologie der Herzinsuffizienz
Pathophysiologie der Herzinsuffizienz
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and ...
Medikamente gegen Herzinsuffizienz: Inotrope Wirkstoffe
Medikamente gegen Herzinsuffizienz: Inotrope Wirkstoffe
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, ...
Medikamente gegen Herzinsuffizienz: Diuretika
Medikamente gegen Herzinsuffizienz: Diuretika
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that ...
Medikamente gegen Herzinsuffizienz: Inhibitoren des Renin-Angiotensin-Systems
Medikamente gegen Herzinsuffizienz: Inhibitoren des Renin-Angiotensin-Systems
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the ...
Medikamente gegen Herzinsuffizienz: β-Blocker
Medikamente gegen Herzinsuffizienz: β-Blocker
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and ...
JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten